Gilead (GILD) Lags Other Biotechs Following HCV Data From Regulus (RGLS)
Go back to Gilead (GILD) Lags Other Biotechs Following HCV Data From Regulus (RGLS)| AbbVie (NYSE: ABBV) | Delayed: 248.00 -1.91 (0.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $249.91 | 52 Week High | $68.12 | |||
| Open | $251.01 | 52 Week Low | $50.71 | |||
| Day High | $251.66 | P/E | 53.80 | |||
| Day Low | $245.05 | EPS | $4.61 | |||
| Volume | 3,086,768 | |||||
| Gilead Sciences (NASDAQ: GILD) | Delayed: 130.07 -4.77 (3.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $134.84 | 52 Week High | $108.63 | |||
| Open | $134.02 | 52 Week Low | $71.39 | |||
| Day High | $134.97 | P/E | 71.86 | |||
| Day Low | $129.27 | EPS | $1.81 | |||
| Volume | 3,403,812 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 123.61 -1.46 (1.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $125.07 | 52 Week High | $65.46 | |||
| Open | $125.12 | 52 Week Low | $47.97 | |||
| Day High | $125.56 | P/E | 84.09 | |||
| Day Low | $122.90 | EPS | $1.47 | |||
| Volume | 5,185,438 | |||||
| REGULUS THERAP (NASDAQ: RGLS) | Delayed: 8.16 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.16 | 52 Week High | $10.60 | |||
| Open | $8.16 | 52 Week Low | $2.13 | |||
| Day High | $8.16 | P/E | 0.21 | |||
| Day Low | $8.16 | EPS | $38.45 | |||
| Volume | 233 | |||||

